Detalles de la búsqueda
1.
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥â¯60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023.
Euro Surveill
; 29(3)2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240061
2.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Euro Surveill
; 28(47)2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37997666
3.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Euro Surveill
; 28(47)2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37997665
4.
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
Influenza Other Respir Viruses
; 18(2): e13255, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38403302
5.
Hybrid immunity and protection against infection during the Omicron wave in Malta.
Emerg Microbes Infect
; 12(1): e2156814, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36510837
6.
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Influenza Other Respir Viruses
; 17(11): e13219, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38025589
7.
Digitalizing and Upgrading Severe Acute Respiratory Infections Surveillance in Malta: System Development.
JMIR Public Health Surveill
; 8(12): e37669, 2022 12 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36227157
Resultados
1 -
7
de 7
1
Próxima >
>>